Chris Radoux
@ChrisRadoux
Followers
220
Following
747
Media
15
Statuses
154
Structural Bioinformatician at Exscientia. Into proteins, data, CG and scientific art
Cambridge, England
Joined September 2010
RT @exscientiaAI: Register now for the @ccdc_cambridge webinar tomorrow! @ChrisRadoux will detail how Exscientia is automating structure-b….
0
5
0
Thank you @ccdc_cambridge for giving me time to talk about one of my favourite subjects - automated drug design. Please do sign up for the webinar if you would like to learn more!.
Don't miss our interview with Chris Radoux, Associate Director of Tractability Informatics @ExscientiaAI, and find out more about the role the CSD and CCDC software play in the #AutomatedDrugDesign workflows at Exscientia. 🔗 #AI
0
1
3
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
693
3K
9K
RT @exscientiaAI: Great story in @NatureBiotech by @Cormac_Sheridan on the promise of precision medicine: Proud to….
0
9
0
RT @exscientiaAI: Don’t miss Ben’s poster if you’re at the #EMBOComp3D workshop this week, discussing how Exscientia is leveraging structur….
0
5
0
Drop by my poster at @ukqsar to see the results of our automated structure-based design workflow. We achieved a 44% hit rate on two targets, with IC50s from 42 nM to ~1 µM. Automated design is allowing us to assess drug targets based on the quality and novelty of designs.
0
1
3
Really looking forward to returning to @ukqsar (in Liverpool this year, a local conference!), this time sharing our work on automated design using Alphafold 2 models.
Learn about Exscientia’s automated structure-based workflows from @ChrisRadoux at this week's @ukqsar Autumn Meeting in Liverpool. .#UKQSAR #AI #automation #alphafold #structurebaseddrugdesign #SBDD
21
0
3
RT @exscientiaAI: Watch #ISMBECCB2023 poster 721 presented by Jake McGreig to learn how we’re automating structure-based drug design to max….
0
2
0
RT @exscientiaAI: We’re proud to announce that Exscientia has been named winner of the #PrixGalien UK 2023 Best Digital Health Solution, re….
0
3
0
RT @exscientiaAI: Don’t miss @ChrisRadoux’s presentation at Kinase 2023 next week to learn about the #AI driven design of our CDK7 inhibito….
soci.org
The 10th SCI/RSC symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes.
0
3
0
Our paper “The Druggable Genome: 20 Years Later” has published in @FrontBioinf! Read @Exscientia’s take on the evolution of the concept & what’s needed next: #automation to produce a knowledge graph, from gene-level-to-protein residue 👉
frontiersin.org
The concept of the druggable genome has been with us for 20 years. During this time, researchers have developed several methods and resources to help assess ...
8
6
10
RT @exscientiaAI: Great story in @endpts on @DeepMind's Alphafold and .@emblebi now making 200 million protein sequences available https://….
0
3
0
RT @luhc: 📣NEW - UK individuals, charities, community groups & businesses can now record their interest in supporting Ukrainians fleeing th….
0
317
0
RT @exscientiaAI: Hotspot mapping automatically identifies opportunities for selectivity in #drugdesign without the need for visual identif….
0
5
0
RT @exscientiaAI: Hotspot mapping is an automated, data-driven technology providing molecular blueprints for prioritising compound #drugdes….
0
16
0
RT @PracticalFrag: Selectivity made easy:.1. Use computational fragment probes on crystallographic structures to find all binding interacti….
0
7
0
RT @JCIM_ACS: Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related Proteins #moleculardesign #BindingSites….
0
6
0
RT @exscientiaAI: We’ve optimised #ML generative models to allow the potential design of significantly higher quality compounds for #drugdi….
0
13
0
RT @exscientiaAI: Proud to deepen our work with @gatesfoundation through a new $70M collaboration to develop broad-spectrum antiviral thera….
0
13
0
RT @ChemicalScience: In this week's #ChemSciPicks, @TheFischerLab at @StJudeResearch show how temperature artifacts in protein structures c….
0
5
0